Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
Filing tables
Filing exhibits
- 10-K Annual report
- 10.41 EX-10.41 Amendment to Research and License Agreements Between Aduro Biotech, Inc. and Janssen Biotech, Inc. Dated November 11, 2015.
- 21.1 EX-21.1 Subsidiaries of Registrant.
- 23.1 EX-23.1 Consent of Deloitte & Touche LLP, Independent Registered Public Accounting Firm.
- 31.1 EX-31.1 Certification of Principal Executive Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Under the Securities Exchange Act of 1934, As Amended.
- 31.2 EX-31.2 Certification of Principal Financial Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Under the Securities Exchange Act of 1934, As Amended.
- 32.1 EX-32.1 Certification of Principal Executive Officer and Principal Financial Officer, As Required by Rules 13A-14(A) and 15D-14(A) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.s.c. 1350).
- Download Excel data file
- View Excel data file
Related press release
KDNY similar filings
Filing view
External links
Exhibit 21.1
Subsidiaries of Registrant
Name of Subsidiary |
| Jurisdiction of Incorporation |
· Aduro GVAX Inc. |
| Delaware |
|
|
|
· Aduro International (Bermuda) Ltd. |
| Bermuda |
|
|
|
· Aduro Netherlands Coöperatief U.A. |
| Netherlands |
|
|
|
· Aduro Biotech Holdings, Europe B.V. |
| Netherlands |
|
|
|
· Aduro Biotech, Europe B.V. |
| Netherlands |